Eliem Therapeutics rebrands as Climb Bio with new name and logo [Seeking Alpha]
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
Private equity firms who have a significant stake must be disappointed along with institutions after Eliem Therapeutics, Inc.'s (NASDAQ:ELYM) market cap dropped by US$231m [Yahoo! Finance]
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
Eliem Therapeutics Announces Additions to its Leadership Team